Close Menu

MDxHealth

Pairings: Sep 29, 2010

Premium

Gregory Critchfield, Mansoor Raza Mirza, Slava Smolokowski, Melissa Thompson, Christopher Thibodeau, Mary-Claire King

Melissa Thompson, Christopher Thibodeau, Savvas Chamberlain, Mike Panayi, Audil Virk, Savvas Damaskinos, Ted Dixon

Under the agreement, GlaxoSmithKline may use a DNA methylation-specific biomarker developed by OncoMethylome in its immunotherapeutics program.

"The cornerstone of our new strategy will be the development and commercialization of high-value predictive and prognostic laboratory developed tests," the firm's CEO said, as the company reported flat first-half revenues.

Exact Sciences gains exclusive, worldwide rights to DNA methylation markers, which will be used in the firm's colorectal cancer test.

The certification was for the firm's lab in Belgium.

OncoMethylome's grant revenues were down for the quarter, but were offset by an increase in commercial sales.

Pairings: Apr 14, 2010

Premium

Jan Groen

In reporting its half-year 2009 financial results last month, OncoMethylome Sciences disclosed that it has inked new partnerships with pharmaceutical companies to discover cancer biomarkers for companion diagnostic development, and is providing companion diagnostic testing services for two clinical trials on personalizing glioblastoma treatments.

The firm's revenues fell year over year due to non-recurring fees it received in 2008.

Pages

NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well.

Resistance to ash dieback disease among some UK ash trees appears polygenic, the Independent reports.

In Nucleic Acids Research this week: sequencing strategy for flash-frozen brain tissue bank samples, new version of ChlamDB, and more.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.